Welldoc is featured by CIO Review and named "Most Promising Healthcare Solutions Provider 2022."...
The Wall Street Journal's Pro Venture Capital features Welldoc and CEO and President Kevin McRaith. The article highlights Welldoc's leadership in the digital health and digital therapeutics space, and ability to continually adapt its business model and product offerings to meet the evolving healthcare market....
The Economist features Welldoc and BlueStar®, our FDA-cleared digital health solution, in their Technology Quarterly edition on how digital health is rapidly becoming an integral part of health care....
Drug Delivery Business News features Welldoc's latest data presented at ATTD 2022, evaluating how the combination of real-time CGM (rtCGM) with a digital health solution impacts glucose control for individuals with Type 2 diabetes not treated with insulin....
FirstWord HealthTech reports on Welldoc's latest data evaluating how the combination of real-time CGM (rtCGM) with a digital health solution impacts glucose control....
